- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Dyadic International Inc (DYAI)
Dyadic International Inc stock price live, this page displays NASDAQ DYAI stock exchange data. View the DYAI premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Dyadic International Inc real time stock price chart below.
What Is the Dyadic International Inc Stock Price Today?
The Dyadic International Inc stock price today is 0.761.
What Is the Stock Symbol for Dyadic International Inc?
The stock symbol for Dyadic International Inc is ""DYAI.""
What Stock Exchange Does Dyadic International Inc Trade On?
Dyadic International Inc is listed and trades on the NASDAQ stock exchange.
Is Dyadic International Inc a Good Stock to Buy?
Determining whether Dyadic International Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the DYAI quote. (ISIN: US26745T1016)
What Is the Dyadic International Inc Stock Price Today?
The Dyadic International Inc stock price today is 0.761.
What Is the Stock Symbol for Dyadic International Inc?
The stock symbol for Dyadic International Inc is ""DYAI.""
What Stock Exchange Does Dyadic International Inc Trade On?
Dyadic International Inc is listed and trades on the NASDAQ stock exchange.
Is Dyadic International Inc a Good Stock to Buy?
Determining whether Dyadic International Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the DYAI quote. (ISIN: US26745T1016)
NASDAQ
Currency in USD
0.761
-0.029(-3.70%)
Real-time Data·
Fair Value
An estimate of a Dyadic's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.761
0.790
52 wk Range
0.711
2.200
DYAI Scorecard
Full Analysis
Stock has fared poorly over the last month
DYAI is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Dyadic's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.7610.790
52 wk Range
0.7112.200
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
DYAI Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Dyadic's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading near 52-week low
- Dyadic prices public offering at $0.95 per share
- Investing.com
- Dyadic prices public offering at $0.95 per share
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Dyadic International Inc Company Profile
Dyadic International, Inc., a biotechnology platform company, develops, produces, and sells industrial enzymes and other proteins in the United States and internationally. It utilizes the C1 platform in pharmaceutical applications, including the development and production of pharmaceutical products. The company offers Dapibus, a protein production platform that enable the rapid development and large-scale manufacture of cost-effective enzymes, proteins, metabolites, and other biologic products for life sciences, food and nutrition, and bioindustrial applications. In addition, it develops DYAI-100, a C1-SARS-CoV-2 recombinant protein RBD vaccine candidate and first C1, which is in phase 1 clinical trial to produce protein tested in humans. The company has a research and development agreement with VTT Technical Research Centre of Finland, Ltd.; license agreement with South Africa’s Rubic One Health; joint development agreement with a Global Food Ingredient Company; and sub-license agreement with Abic Biological Laboratories Ltd., Alphazyme, LLC, and Abic Biological Laboratories Ltd. Dyadic International, Inc. was founded in 1979 and is headquartered in Jupiter, Florida.
Dyadic International Inc Earnings Call Summary for Q2/2025
- Revenue grew to $967,000 from $386,000 YoY, slightly exceeding forecasts; EPS of -0.06 met expectations
- Net loss decreased to $1,794,000; company aims for cash flow positivity by 2026 and increased profitability in 2027
- Stock declined 3.53% post-earnings to $0.85, despite positive results, reflecting investor caution on path to profitability
- Rebranded to Dyadic Applied Biosolutions, focusing on non-therapeutic protein markets; completed $5.3M equity raise
- Targeting product launches for DNase-one, transferrin, and albumin over next two years to drive future growth
Last Updated: 13/08/2025, 22:52
Read Full TranscriptCompare DYAI to Peers and Sector
Metrics to compare | DYAI | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipDYAIPeersSector | |
|---|---|---|---|---|
P/E Ratio | −5.1x | −0.5x | −0.6x | |
PEG Ratio | −0.17 | −0.02 | 0.00 | |
Price/Book | −54.0x | 2.4x | 2.6x | |
Price / LTM Sales | 6.9x | 8.8x | 3.3x | |
Upside (Analyst Target) | - | 297.1% | 40.1% | |
Fair Value Upside | Unlock | 35.5% | 5.3% | Unlock |
Earnings
Latest Release
Aug 13, 2025
EPS / Forecast
-0.06 / --
Revenue / Forecast
966.63K / --
People Also Watch
FAQ
What Stock Exchange Does Dyadic Trade On?
Dyadic is listed and trades on the Nasdaq Stock Exchange stock exchange.
What Is the Stock Symbol for Dyadic?
The stock symbol for Dyadic is "DYAI."
What Is the Dyadic Market Cap?
As of today, Dyadic market cap is 27.54M.
What Is Dyadic's Earnings Per Share (TTM)?
The Dyadic EPS (TTM) is -0.19.
When Is the Next Dyadic Earnings Date?
Dyadic will release its next earnings report on 04 Nov 2025.
From a Technical Analysis Perspective, Is DYAI a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Dyadic Stock Split?
Dyadic has split 0 times.
How Many Employees Does Dyadic Have?
Dyadic has 6 employees.
What is the current trading status of Dyadic (DYAI)?
As of 20 Aug 2025, Dyadic (DYAI) is trading at a price of 0.76, with a previous close of 0.79. The stock has fluctuated within a day range of 0.76 to 0.79, while its 52-week range spans from 0.71 to 2.20.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.